Benzinga's Top Downgrades

Analysts at Barclays downgraded athenahealth, Inc ATHN from Equal-weight to Underweight. The price target for AthenaHealth has been lowered from $140 to $110. AthenaHealth shares closed at $162.98 on Monday. Analysts at Brean Capital downgraded Osiris Therapeutics, Inc. OSIR from Hold to Sell. The price target for Osiris Therapeutics is set to $8. Osiris Therapeutics shares closed at $13.98 on Monday. Wedbush downgraded Polaris Industries Inc. PII from Outperform to Neutral. The price target for Polaris Industries has been lowered from $156 to $117. Polaris Industries shares closed at $105.49 on Monday. RBC Capital downgraded Urban Outfitters, Inc. URBN from Outperform to Sector Perform. The price target for Urban Outfitters has been lowered from $32 to $23. Urban Outfitters shares closed at $22.67 on Monday. Analysts at Sterne Agee CRT downgraded Five Below Inc FIVE from Buy to Neutral. The price target for Five Below has been lowered to $30. Five Below shares closed at $28.49 on Monday. BMO Capital downgraded Kindred Biosciences Inc KIN from Outperform to Market Perform. The price target for Kindred Biosciences has been lowered from $14 to $5. Kindred Biosciences shares closed at $4.73 on Monday. Analysts at Oppenheimer downgraded Hess Corp. HES from Outperform to Perform. Hess shares closed at $61.84 on Monday. Atlantic Equities downgraded W W Grainger Inc GWW from Neutral to Underweight. The price target for W W Grainger has been lowered from $220 to $183. W W Grainger shares closed at $198.28 on Monday. Analysts at KeyBanc downgraded Airgas, Inc. ARG from Overweight to Sector Weight. Airgas shares closed at $106.18 on Monday. Analysts at Goldman Sachs downgraded Clovis Oncology Inc CLVS from Buy to Neutral. The price target for Clovis Oncology has been lowered from $123 to $23. Clovis Oncology shares closed at $30.24 on Monday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsTop Downgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!